Related Experiment Videos
Cardiolipin binding a light chain from lupus-prone mice
B Pereira1, C R Benedict, A Le
1Department of Internal Medicine, University of Texas Health Science Center, Houston 77030, USA.
Biochemistry
|March 7, 1998
Summary
Systemic lupus erythematosus autoantibodies can bind cardiolipin using only their light-chain variable (VL) sequences. This finding suggests antigen specificity may reside exclusively in the VL sequence for some antibodies.
Area of Science:
- Immunology
- Molecular Biology
- Autoimmunity Research
Background:
- Autoantibodies in systemic lupus erythematosus (SLE) target conserved molecules like nucleic acids and phospholipids.
- Analysis of autoantibody variable gene sequences (VH and VL) reveals a limited repertoire.
- Monoclonal antibodies from lupus-prone mice were studied for cardiolipin reactivity.
Purpose of the Study:
- To investigate the role of heavy-chain variable (VH) and light-chain variable (VL) sequences in cardiolipin autoantibody binding.
- To determine if the light-chain variable sequence alone can confer antigen-binding specificity.
Main Methods:
- Sequencing of VH and VL regions of monoclonal antibodies A1.72 and A1.84.
- Recombinant expression of single-chain variable fragments (scFv) combining VL 72/84 with different VH sequences.
- Expression of the VL 72/84 sequence alone.
- Immunoaffinity purification using cardiolipin liposomes and measurement of dissociation constants (Kd).
Main Results:
- Antibodies A1.72 and A1.84 shared identical VL sequences (VL 72/84) but differed in VH sequences.
- The VL 72/84 sequence alone, and when combined with various VH sequences, conferred cardiolipin-binding activity.
- The dissociation constant of the isolated VL chain for cardiolipin was comparable to the intact antibody.
Conclusions:
- The light-chain variable (VL) sequence alone can mediate direct binding to cardiolipin.
- Antigen specificity for cardiolipin may reside exclusively within the VL sequence in certain autoantibodies.
- This challenges the traditional view of antigen binding requiring contributions from both VH and VL domains.